Epidemiology, Development and Treatment of End-stage Renal Failure in Type 2 (non-insulin-dependent) Diabetes Mellitus. The Case of Mainland France and of Overseas French Territories

Overview

Journal Diabetologia

Specialty Endocrinology

Date 1993 Oct 1

PMID 8243863

Citations 2

Authors

D J Cordonnier

D Zmirou

P Y Benhamou

S Halimi

F Ledoux

J Guiserix

Affiliations

Soon will be listed here.

Abstract

The prevalence of diabetes mellitus among patients treated for end-stage renal failure by dialysis in France was studied in two stages (UREMIDIAB Study). The first stage consisted of a questionnaire which was mailed to all dialysis centres in mainland France. The response rate was 80.8%, resulting in a study population of 12,903 patients. Of these patients 884 were declared diabetic (6.9%). Later 295 of them were interviewed by seven specially-trained physicians who checked the medical records together with the nephrologist in charge. Plasma C-peptide was measured in almost all of the patients. Effectively, 1.4% were found to have Type 1 diabetes and 5.5%, Type 2. Diabetic nephropathy was found to be the only primary renal diagnosis among 93.9% of Type 1 diabetic patients and 36.8% of Type 2. Of the latter 51.6% had a non-diabetic cause of renal failure. In the second stage a survey was later conducted in 13 of 14 dialysis centres located in the remote overseas French territories. Among 934 patients 1.04% were Type 1 diabetic and 19.67% Type 2 (22.9% altogether). Type 2 diabetic patients treated overseas were essentially non-Caucasians (92.6%). The sex ratio was 0.54 in the overseas territories vs 1.4 in the mainland. We conclude that the prevalence of diabetes among people on dialysis is low in mainland France. But there are striking differences in the prevalence of Type 2 diabetes among dialysis patients in mainland France and its overseas territories. These differences are not related to access to dialysis facilities.

Citing Articles

End stage renal disease in French Guiana (data from R.E.I.N registry): South American or French?.

Rochemont D, Meddeb M, Roura R, Couchoud C, Nacher M, Basurko C BMC Nephrol. 2017; 18(1):207.

PMID: 28666409 PMC: 5493068. DOI: 10.1186/s12882-017-0614-6.

Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM.

Doi Y, Yoshizumi H, Yoshinari M, Iino K, Yamamoto M, Ichikawa K Diabetologia. 1996; 39(1):97-102.

PMID: 8720609 DOI: 10.1007/BF00400419.

References

Ordonez J, Hiatt R . Comparison of type II and type I diabetics treated for end-stage renal disease in a large prepaid health plan population. Nephron. 1989; 51(4):524-9. DOI: 10.1159/000185387. View

Grenfell A, Bewick M, Parsons V, Snowden S, Taube D, Watkins P . Non-insulin-dependent diabetes and renal replacement therapy. Diabet Med. 1988; 5(2):172-6. DOI: 10.1111/j.1464-5491.1988.tb00966.x. View

. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. Diabetes. 1979; 28(12):1039-57. DOI: 10.2337/diab.28.12.1039. View

Odaka M . Mortality in chronic dialysis patients in Japan. Am J Kidney Dis. 1990; 15(5):410-3. DOI: 10.1016/s0272-6386(12)70358-x. View

Parving H, Gall M, Skott P, Jorgensen H, Lokkegaard H, Jorgensen F . Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. Kidney Int. 1992; 41(4):758-62. DOI: 10.1038/ki.1992.118. View

Disney A . Dialysis treatment in Australia, 1982 to 1988. Am J Kidney Dis. 1990; 15(5):402-9. DOI: 10.1016/s0272-6386(12)70357-8. View

Amoah E, Glickman J, Malchoff C, STURGILL B, Kaiser D, Bolton W . Clinical identification of nondiabetic renal disease in diabetic patients with type I and type II disease presenting with renal dysfunction. Am J Nephrol. 1988; 8(3):204-11. DOI: 10.1159/000167584. View

Pugh J, Stern M, Haffner S, Eifler C, Zapata M . Excess incidence of treatment of end-stage renal disease in Mexican Americans. Am J Epidemiol. 1988; 127(1):135-44. DOI: 10.1093/oxfordjournals.aje.a114773. View

Brunner F, Brynger H, Challah S, Fassbinder W, Geerlings W, Selwood N . Renal replacement therapy in patients with diabetic nephropathy, 1980-1985. Report from the European Dialysis and Transplant Association Registry. Nephrol Dial Transplant. 1988; 3(5):585-95. DOI: 10.1093/oxfordjournals.ndt.a091710. View

10.

Mogensen C, Schmitz A, Christensen C . Comparative renal pathophysiology relevant to IDDM and NIDDM patients. Diabetes Metab Rev. 1988; 4(5):453-83. DOI: 10.1002/dmr.5610040504. View

11.

Benhamou P, Marwah T, Balducci F, Zmirou D, Borgel F, Cordonnier D . Classification of diabetes in patients with end-stage renal disease. Validation of clinical criteria according to fasting plasma C-peptide. Clin Nephrol. 1992; 38(5):239-44. View

12.

Mailloux L, Bellucci A, Mossey R, Napolitano B, Moore T, Wilkes B . Predictors of survival in patients undergoing dialysis. Am J Med. 1988; 84(5):855-62. DOI: 10.1016/0002-9343(88)90063-0. View

13.

Nelson R, Newman J, Knowler W, SIEVERS M, Kunzelman C, Pettitt D . Incidence of end-stage renal disease in type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians. Diabetologia. 1988; 31(10):730-6. DOI: 10.1007/BF00274774. View

14.

Held P, Brunner F, Odaka M, Garcia J, Port F, Gaylin D . Five-year survival for end-stage renal disease patients in the United States, Europe, and Japan, 1982 to 1987. Am J Kidney Dis. 1990; 15(5):451-7. DOI: 10.1016/s0272-6386(12)70363-3. View

15.

Palmisano J, Lebovitz H . Renal function in black Americans with type II diabetes. J Diabet Complications. 1989; 3(1):40-4. DOI: 10.1016/0891-6632(89)90009-3. View

16.

Borgel F, Benhamou P, Zmirou D, Balducci F, Halimi S, Cordonnier D . Assessment of handicap in chronic dialysis diabetic patients (Uremidiab section study). Scand J Rehabil Med. 1992; 24(4):203-8. View

17.

Ritz E, Nowack R, Fliser D, Koch M, Tschope W . Type II diabetes mellitus: is the renal risk adequately appreciated?. Nephrol Dial Transplant. 1991; 6(10):679-82. DOI: 10.1093/ndt/6.10.679. View

18.

Zimmet P, King H, Taylor R, Raper L, Balkau B, Borger J . The high prevalence of diabetes mellitus, impaired glucose tolerance and diabetic retinopathy in Nauru--the 1982 survey. Diabetes Res. 1984; 1(1):13-8. View

19.

Zmirou D, Benhamou P, Cordonnier D, Borgel F, Balducci F, Papoz L . Diabetes mellitus prevalence among dialysed patients in France (UREMIDIAB study). Nephrol Dial Transplant. 1992; 7(11):1092-7. View

20.

Cowie C, Port F, Wolfe R, Savage P, Moll P, Hawthorne V . Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med. 1989; 321(16):1074-9. DOI: 10.1056/NEJM198910193211603. View